OPKO Health, Inc. (OPK)

OPKO Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	863.5	1,004	1,775	1,435	901.94
Revenue Growth (YoY)	-14.01%	-43.42%	23.64%	59.15%	-8.92%
Cost of Revenue	545.37	715.98	1,193	894.41	572.48
Gross Profit	318.13	288.22	581.52	541.01	329.45
Selling, General & Admin	300.56	372.67	468.86	355.57	343.31
Research & Development	89.59	73.89	76.85	75.32	117.87
Other Operating Expenses	85	67.91	17.07	52.4	142.33
Operating Expenses	475.15	514.47	562.77	483.29	603.5
Operating Income	-157.02	-226.25	18.75	57.71	-274.05
Interest Expense / Income	13.51	12.06	18.88	21.93	21.52
Other Expense / Income	13.9	153.6	14.52	-12.42	12.3
Pretax Income	-184.43	-391.9	-14.65	48.2	-307.87
Income Tax	4.44	-63.5	15.49	17.62	7.06
Net Income	-188.86	-328.41	-30.14	30.59	-314.93
Shares Outstanding (Basic)	752	719	648	641	595
Shares Outstanding (Diluted)	752	719	648	641	595
Shares Change	4.55%	10.95%	1.16%	7.59%	5.74%
EPS (Basic)	-0.25	-0.46	-0.05	0.05	-0.53
EPS (Diluted)	-0.25	-0.46	-0.05	0.05	-0.53
Free Cash Flow	-41.76	-117.82	72.21	6.04	-184.59
Free Cash Flow Per Share	-0.06	-0.16	0.11	0.01	-0.31
Gross Margin	36.84%	28.70%	32.77%	37.69%	36.53%
Operating Margin	-18.18%	-22.53%	1.06%	4.02%	-30.38%
Profit Margin	-21.87%	-32.70%	-1.70%	2.13%	-34.92%
Free Cash Flow Margin	-4.84%	-11.73%	4.07%	0.42%	-20.47%
Effective Tax Rate	-	-	-	36.55%	-
EBITDA	-65.62	-271.19	82.94	155.5	-192.54
EBITDA Margin	-7.60%	-27.01%	4.67%	10.83%	-21.35%
Depreciation & Amortization	105.3	108.66	78.72	85.36	93.81
EBIT	-170.92	-379.85	4.23	70.14	-286.35
EBIT Margin	-19.79%	-37.83%	0.24%	4.89%	-31.75%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).